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BDNF - its role in clinical course of potential brain recov-
ery during multiple sclerosis and stroke 
Brain-derived neurotrophic factor (BDNF) belongs to the
family of neurotrophins originally described to be crucial
for neuronal differentiation and survival. BDNF is known to
be involved in myelin formation and promote remyelina-
tion in multiple sclerosis (MS) and is also essential for post-
stroke recovery in rodents and in brain neurodegeneration..
BDNF-196 G>A (Met/Val) polymorphisms has been shown
to have functional consequences, whereas for -270 C>T it
has not been fully elucidated. The Met allele has been asso-
ciated with impairments in intracellular trafficking and ac-
tivity-dependent secretion of BDNF in neurons and
neurosecretory cells. In all brain processes where acute injury
or choric degeneration occur accumulation of inflammatory
cells may additionally increase production of trophic factors.
In our studies we have determined impact of BDNF single
nucleotide polymorphisms (SNPs): -196 G>A (Val66Met)
and -270 C>T on: 1) MS susceptibility and its the clinical
course, 2) human stroke early outcome and 3) post stroke re-
covery after rehabilitation. According to the study design
suitable neurological and outcome measures were used.
The tendencies of influence of BDNF polymorphisms on
studied parameters have been noticed. For example there
was higher occurrence of BDNF -270 CC genotype in pa-
tients with hemorrhagic than ischemic stroke (96% versus
86%,). In hemorrhagic stroke BDNF -196 GG carriers
scored better in NIHSS at admission and after 7 days. No ef-
fect of determined BDNF polymorphisms on functional
motor or language recovery was found. However, in patients
who were admitted to the rehabilitation ward within 3
months from ischemic stroke onsets some significant effect
of -196 G>A and -270 C>T polymorphisms on stroke out-
come differences in men and women were noted. It was
found that men with BDNF -196 GG scored in discharge
Rankin scale significantly better than women (median 2,0
versus 3,0, p=0,0142). Moreover, men with -270 CT scored
better than women both in Rankin and Barthel scale at dis-
charge (respectively median 2,0 versus 4,0; p=0,0139 and
median 18,5 versus 8,5; p=0,0144). When BDNF -270 CT
and -196 GG were combined, men scored better in both
Rankin and Barthel scale at discharge (respectively median
2,0 versus 4,0; p=0,0079 and median 18,0 versus 9,0;
p=0,0142).
Different effect of BDNF SNPs on clinical course and out-
come of neurological diseases may be explained by influence
of many different genetic and non-genetic factors involved
in processes of neurodegeneration and post ischemia brain
recovery. Further studies are needed to elucidate influence of
endogenous neurotrophic factors in neurological diseases.
52nd International Neuropsychiatric Pula Congress
BDNF GEN POLYMORPHISM - INFLUENCE ON CLINICAL
MANIFESTATIONS AND OUTCOME 
OF NEUROLOGICAL DISEASES
Anna Czlonkowska, Dagmara Mirowska-Guzel
2nd Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957 Warsaw, Poland
Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 
Krakowskie Przedmiescie 26/28, 00-927 Warsaw, Poland 
